An interventional study of Healthy Body & Mind Program in Cognitive Decline and Osteoarthritis, sponsored by The University of New South Wales. Recruiting at 1 site in Australia. Open to participants aged 55 Years and older. Per ClinicalTrials.gov, last updated 2023-10-06.
Sponsored by The University of New South Wales · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 57 studies in Cognitive Dysfunction with a site in Australia — 12 open to participants now, 22 under way, 9 of them phase 3. Cognitive Dysfunction · Australia.
Among the 57 studies in Cognitive Dysfunction with a site in Australia, this one is the 47th largest by planned enrollment of the 51 interventional ones that give a count, is one of 8 that started in 2023, is one of 15 with no phase, reaches primary completion later than 2 of the 21 other live ones, and was the 48th registered.
3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.
Browse Cognitive Dysfunction studies →12 of the 57 studies in Cognitive Dysfunction with a site in Australia are open now. Recruiting first, the newest first:
Eli Lilly and Company · Sites in Australia, United States, New Zealand and 1 more country
Ages 50–85
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation · Sites in Australia, Austria, Belgium and 14 more countries
Ages 18+
Bristol-Myers Squibb · Sites in Australia, United States, Argentina and 14 more countries
Ages 60–85
Bristol-Myers Squibb · Sites in Australia, United States, Argentina and 16 more countries
Ages 60–85
Hoffmann-La Roche · Sites in Australia, United States, Argentina and 12 more countries
Ages 50–90
A study can be open while its sites in Australia have not opened yet or have stopped. Only those recruiting at a site in Australia →
Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.
This study: 55 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
57 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 6 · Phase 2 16 · Phase 3 16 · Phase 4 2
First in 2003; this study’s year is marked. 8 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 64 across 2,804 interventional studies indexed under Cognitive Dysfunction.
Median enrollment 167 across the 51 interventional studies, 5,542 across the 6 observational. Of the 34 that completed or were terminated, 14 (41%) have results posted.
This tab as a report to print or save as PDF → With an account.
31 of 57 have an industry lead sponsor. The 10 most frequent:
The University of New South Wales is the lead sponsor of 66 studies on the registry; 6 are open to participants now.
The University of New South Wales has 2 studies filed under Cognitive Dysfunction — fewer than ten, so there is no comparison to draw.
5 of the studies in Cognitive Dysfunction with a site in Australia that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03887455Phase 3Eisai Inc.A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease | 2026-12-31 |
| NCT05230758Phase 3Donald MabbottEffect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour | 2027-11-30 |
| NCT06207942Region SkaneStepcare Extended Follow-up Substudy | 2027-01 |
| NCT07224139Anne MurraySex-specific Risk Factors and Trajectories of Blood Biomarkers for Alzheimer's Disease and Related Dementias | 2027-08 |
| NCT07598370Eli Lilly and CompanyA Study of LY3439539 in Participants With Alzheimer's Disease | 2027-08 |
Add all 5 to your calendar (.ics) → With an account.
Among the 57 studies in Cognitive Dysfunction with a site in Australia, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this pilot randomised clinical trial is to compare a 12-week Healthy Body \& Mind Program to usual care in older adults living with cognitive decline and osteoarthritis.
The main questions it aims to answer are:
Participants will complete a co-designed and multidisciplinary 12-week program that includes physical activity and lifestyle education (nutrition, social activity and managing anxiety/depression). Researchers will compare outcomes between the intervention group and a wait-list control to see if there are difference in outcome measures (quality of life, cognition, pain, anxiety/depression, physical function).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Healthy Body \& Mind Program: In summary, the program includes two visits to the University of New South Wales (UNSW) Medicine \& Health Lifestyle Clinic at the beginning and end of the program for Initial and Final Assessments, and two weekly sessions for 12 weeks (24 sessions in total) to the UNSW Medicine \& Health Lifestyle Clinic to complete the Healthy Body \& Mind Program. Participants will also be invited to take part in a focus group either at the clinic or online (via Teams/ zoom) at the end of the program.
Other: Healthy Body & Mind Program
Usual care. Participants will not be recruited if they are taking part in another research intervention or receiving treatment other than usual care.
12-week physical activity and lifestyle education program
Health-related quality of life questionnaire
EuroQoL health-related quality of life (EQ-5D; https://euroqol.org/); Score range 0-1; 1 indicating full health, 0 indicating bad health.
Time frame: 12 weeks
Cognition questionnaire
Montreal Cognitive Assessment (MoCA); Score range 0-30; higher scores mean better cognition. Measure can also be broken down into subscales.
Time frame: 12 weeks
Chronic pain questionnaire
Western Ontario and McMaster Universities Arthritis Index (WOMAC); Score range 0-96; 0 represents best health, higher scores indicate more pain. Measure can also be broken down into subscales (e.g., pain and function).
Time frame: 12 weeks
Depression, anxiety & stress questionnaire
Depression Anxiety Stress Scales (DASS-21); Score range 0-21; higher scores mean worse psychological health. Measure can also be broken down into subscales: depression, anxiety \& stress.
Time frame: 12 weeks
Physical function: 6-minute walk test
Assesses distance in metres walked over 6 minutes as a sub-maximal test of aerobic capacity/endurance. Higher number of metres walked means better physical function and aerobic capacity.
Time frame: 12 weeks
Cardiovascular disease (CVD) risk profile questionnaire
ADCVD (https://tools.acc.org/ascvd-risk-estimator-plus/#!/calculate/estimate/). Tool calculated % risk, higher % indicates greater risk for CVD.
Time frame: 12 weeks
Sleep questionnaire
Pittsburgh Sleep Quality Index (PSQI); Score range 0-21; higher scores indicate worse sleep)
Time frame: 12 weeks
Physical function: handgrip strength physical test
Accesses physical strength in kilograms (kg). Average score of 3 attempts on each hand using a dynamometer; higher kg indicates more strength.
Time frame: 12 weeks
Physical function: single leg stance test (balance) physical test
Physical test used to assess static postural and balance control. The participant must stand unassisted on one leg and is timed in seconds from the time one foot is flexed off the floor to the time when it touches the ground or the standing leg or an arm leaves the hips. Higher number of seconds indicates better balance.
Time frame: 12 weeks
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2023 (actual). Primary completion is estimated for Jun 2024, 9 months after the start.
Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's planned 9 months is below that.
Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The University of New South Wales